Chronotherapeutics - A chronopharmaceutical approach to drug delivery in the treatment of asthma

Journal of Controlled Release

Volumn 163, Issue 3, 2012, Pages 353-360

  Nainwal, Nidhi ^a  

^a GRD ^*  (India)

Author keywords

Bronchial asthma; Chronobiology; Chronopharmaceutics; Chronotherapy; Circadian rhythm

Indexed keywords

BRONCHIAL ASTHMA; CHRONOBIOLOGY; CHRONOPHARMACEUTICS; CHRONOTHERAPY; CIRCADIAN RHYTHMS;

DRUG DELIVERY;

DISEASES;

AMINOPHYLLINE; BAMBUTEROL; BECLOMETASONE; BUDESONIDE; CICLESONIDE; CORTICOSTEROID; CORTISONE ACETATE; CROMOGLYCATE DISODIUM; DUTIMELAN; FLUNISOLIDE; FLUTICASONE; FLUTICASONE PROPIONATE; FORMOTEROL; METHYLPREDNISOLONE; MONTELUKAST; NEDOCROMIL; PRANLUKAST; PREDNISOLONE ACETATE; SALBUTAMOL; SALBUTAMOL SULFATE; SALMETEROL; SALMETEROL XINAFOATE; THEOPHYLLINE; TRIAMCINOLONE; TULOBUTEROL; ZILEUTON;

AEROSOL; AIRWAY OBSTRUCTION; ASTHMA; CHRONOTHERAPY; CIRCADIAN RHYTHM; COMPETITIVE INHIBITION; CONTROLLED DRUG RELEASE; CORTICOSTEROID THERAPY; COUGHING; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FORMULATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG SAFETY; EVENING DOSAGE; HUMAN; INFLAMMATORY CELL; INFUSION PUMP; METERED DOSE INHALER; MINIPUMP; MORNING DOSAGE; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; REVIEW; TABLET; THERAPY EFFECT; TRANSDERMAL PATCH; WHEEZING;

ADRENERGIC BETA-2 RECEPTOR ANTAGONISTS; ANTI-ASTHMATIC AGENTS; ASTHMA; DRUG CHRONOTHERAPY; GLUCOCORTICOIDS; HUMANS; LEUKOTRIENE ANTAGONISTS; THEOPHYLLINE;

EID: 84867618281     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.09.012     Document Type: Review

References (101)

1. B. Lemmer Chronobiology, drug-delivery and chronotherapeutics Adv. Drug Deliv. Rev. 59 2007 825 827
2. T. Bussemer, N.A. Peppas, and R. Bodmeier Evaluation of the swelling, hydration and rupturing properties of the swelling layer of a rupturable pulsatile drug delivery system Eur. J. Pharm. Biopharm. 56 2003 261 270 (Pubitemid 37072111)
3. F. Pozzi, P. Furlani, A. Gazzaniga, S.S. Davis, and I.R. Wilding The time clock system: a new oral dosage form for fast and complete release of drug after a predetermined lag time J. Control. Release 31 1994 99 108
4. B.B.C. Youan Chronopharmaceutical drug delivery systems: hurdles, hype or hope? Adv. Drug Deliv. Rev. 62 2010 898 903
5. B.B.C. Youan Chronopharmaceutics: Science and Technology for Biological Rhythm Guided Therapy and Prevention of Diseases 2009 John Wiley & Sons Hoboken, NJ, USA
6. B.B.C. Youan Chronopharmaceutics: gimmick or clinically relevant approach to drug delivery J. Control. Release 98 2004 337 353
7. Z. Khan, V. Pillay, Y.E. Choonara, and L.C. du Toit Drug delivery technologies for chronotherapeutic applications Pharm. Dev. Technol. 14 2009 602 612
8. P. Sher, G. Ingavle, S. Ponrathnam, J.R. Benson, N.H. Li, and A.P. Pawar Novel/conceptual floating pulsatile system using high internal phase emulsion based porous material intended for chronotherapy AAPS Pharm. Sci. Technol. 10 2009 1368 1380
9. P. Roy, and A. Shahiwala Multiparticulate formulation approach to pulsatile drug delivery: current perspectives J. Control. Release 134 2009 74 80
10. D. Hradetzky Transdermal drug delivery devices for chronotherapy Med. Device Technol. 19 2008 45 47
11. H. Kato, O. Nagata, M. Yamazaki, T. Suzuki, and Y. Nakano Development of transdermal formulation of tulobuterol for the treatment of bronchial asthma Yakugaku Zasshi 122 2002 57 69
12. S.Y. Lin, C.J. Ho, and M.J. Li Precision and reproducibility of temperature response of a thermo-responsive membrane embedded by binary liquid crystals for drug delivery J. Control. Release 73 2001 293 301
13. H. Shiohira, M. Fujii, N. Koizumi, M. Kondoh, and Y. Watanabe Novel chronotherapeutic rectal aminophylline delivery system for therapy of asthma Int. J. Pharm. 379 2009 119 124
14. S. You, and W. Li Administration of nanodrugs in proper menstrual stage for maximal drug retention in breast cancer Med. Hypotheses 71 2008 141 147
15. G.D. Rosenberg, and D.J. Simmons Rhythmic dentinogenesis in the rabbit incisor: circadian, ultradian and infradian periods Calcif. Tissue Int. 32 2006 29 44
16. M.H. Smolensky, and N.A. Peppas Chronobiology, drug delivery and chronopharmaceutics Adv. Drug Deliv. Rev. 59 2007 828 851
17. A. Reinberg Clinical chronopharmacology. An experimental basis for chronotherapy A. Reinberg, M.H. Smolensky, Biological Rhythms and Medicine, Cellular, Metabolic, Physiopathologic and Pharmacologic Aspects 1983 Springer Heidelberg 211 263
18. A.E. Reinberg Concepts of circadian chronopharmacology Temporal Control of Drug Delivery W.J.M. Hrushesky, R. Langer, F. Theeuwes, Ann. N. Y. Acad. Sci. vol. 618 1991 102 115
19. The Global Initiative for Asthma (GINA) Report, Global Strategy for Asthma Management and Prevention, evidence-based guidelines for asthma management and prevention Updated December 2008 Available from http://www.ginasthma.com/
20. Y. Kikuchi, S. Okabe, G. Tamura, W. Hida, M. Homma, K. Shirato, and T. Takishima Chemosensitivity and perception of dyspnea in patients with a history of near-fatal asthma N. Engl. J. Med. 330 1994 1329 1334 (Pubitemid 24136055)
21. American Thoracic Society Standardization of spirometry - 1994 update Am. Rev. Respir. Dis. 130 Nov. 1987 1285 1298
22. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma National Institutes of Health Publication No. 97-4051, Bethesda, MD April 1997
23. P.J. Barnes Pathophysiology of asthma P.J. Barnes, I.W. Rodger, N.C. Thomson, Asthma Basic Mechanisms and Clinical Management 3rd ed. 1998 Academic Press San Diego 487 506
24. J.W. Georgitis The 1997 Asthma Management Guidelines and therapeutic issues relating to the treatment of asthma Chest 115 1999 210 217 (Pubitemid 29047077)
25. N. Burioka, Y. Fukuoka, S. Koyanagi, M. Miyata, M. Takata, H. Chikumi, H. Takane, M. Watanabe, M. Endo, T. Sako, and H. Suyama Asthma: chronopharmacotherapy and the molecular clock Adv. Drug Deliv. Rev. 62 2010 946 955
26. M.H. Smolensky, B. Lemmer, and A.E. Reinberg Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma Adv. Drug Deliv. Rev. 59 2007 852 882 (Pubitemid 47542292)
27. A.N. Newman Taylor, R.J. Davies, D.J. Hendrick, and J. Pepys Recurrent nocturnal asthmatic reactions to bronchial provocation tests Clin. Allergy 9 1979 213 219 (Pubitemid 9208119)
28. C. Waldman-Wagner Asthma Care and Patient Education: The Nurse's Role 1990 Allen & Hanburys Research Triangle Park, NC
29. S.M. Lewis, I.C. Collier, and M.M. Heitkemper Medical Surgical Nursing: Assessment and Management of Clinical Problems 4th ed. 1996 Mosby St. Louis
30. M.H. Smolensky, and G.E. D'Alonzo Progress in the chronotherapy of nocturnal asthma P.H. Redfern, B. Lemmer, Physiology and Pharmacology of Biological Rhythms, Handbook of Pharmacology vol. 125 1997 Springer-Verlag Heidelberg 205 249
31. J.M. Drazen Bronchial asthma G.L. Baum, J.D. Crapo, B.R. Celli, J.B. Karlinsky, 6th ed. Textbook of Pulmonary Diseases vol. II 1997 Lippincott-Raven Philadelphia 791 805
32. A.S. Mandal, N. Biswas, K.M. Karim, A. Guha, S. Chatterjee, M. Behera, and K. Kuotsu Drug delivery system based on chronobiology - a review J. Control. Release 147 2010 314 325
33. E.R. McFadden When to use high-dose inhaled steroids J. Respir. Dis. 12 11 1991 1005 1012
34. J.G. Harter, W.J. Reddy, and G.W. Thorn Studies on an intermittent corticosteroid dosage regimen N. Engl. J. Med. 296 1963 591 595
35. G.E. D'Alonzo, M.H. Smolensky, S. Feldman, L.A. Gianotti, M.B. Emerson, H. Staudinger, and V.M. Steinijans Twenty-four-hour lung function in adult patients with asthma: chronoptimized theophylline therapy once daily dosing in the evening versus conventional twice-daily dosing Am. Rev. Respir. Dis. 142 1990 84 90 (Pubitemid 20224583)
36. H. Neuenkirchen, J.H. Wilkens, M. Oellerich, and G.W. Sybrecht Nocturnal asthma: effect of a once per evening dose of sustained-release theophylline Eur. J. Respir. Dis. 66 1985 196 204 (Pubitemid 15167178)
37. Alessandra Maroni, Lucia Zema, Maria Dorly Del Curto, Giulia Loreti, and Andrea Gazzaniga Oral pulsatile delivery: rationale and chronopharmaceutical formulations Int. J. Pharm. 398 2010 1 8
38. Zuzana Diamant, J. Diderik Boot, and J. Christian Virchow Summing up 100 years of asthma Respir. Med. 101 2007 378 388 (Pubitemid 46196344)
39. E.O. Vianna, and R.J. Martin Recent innovations in asthma therapy Drugs Today (Barc.) 34 1998 341 351 (Pubitemid 28216323)
40. J.G. Harter, W.J. Reddy, and G.W. Thorn Studies on an intermittent corticosteroid dosage regimen N. Engl. J. Med. 296 1963 591 595
41. A. Reinberg, P. Guillet, P. Gervais, J. Ghata, D. Vignaud, and C. Abulker One-month chronocorticotherapy (Dutimelan 8-15 mite): control of the asthma condition without adrenal suppression and circadian alteration Chronobiologia 4 1977 295 312 (Pubitemid 8356783)
42. L. Peterson Trends-in-Medicine 2002 5 6 http://www.trends-in-medicine. com/Sept2002/EuroResp092p.pdf
43. M.J. Dyer, D.M. Halpin, and K. Stein Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone versus inhaled fluticasone for chronic asthma in adults: a systematic review BMC Fam. Pract. 7 2006 34
44. P.J. Barnes Effect of corticosteroids on airway hyperresponsiveness Am. Rev. Respir. Dis. 141 1990 S70 S76 (Pubitemid 20063273)
45. P.J. Barnes Inhaled glucocorticoids for asthma N. Eng. J. Med. 332 1995 868 875
46. B.J. Lipworth, and C.M. Jackson Safety of inhaled and intranasal corticosteroids: lessons for the new millennium Drug Saf. 23 2000 11 33 (Pubitemid 30455915)
47. H. Derendorf, M. Hübner, B. Drewelow, U. Fuhr, C.H. Gleiter, B. Lemmer, G. Mikus, I. Roots, A. Ziegler, and D. Ukena Ciclesonide - Pharmakokinetische und pharmakodynamische Eigenschaften Arzneimitteltherapie 25 2007 89 94
48. S.M. Holliday, D. Faulds, and E.M. Sorkin Inhaled fluticasone propionate: a review of its pharmacodynamics and pharmacokinetic properties, and therapeutic use in asthma Drugs 47 1994 319 331
49. R. Nave, W. Meyer, R. Fuhst, and K. Zech Formation of fatty acid conjugates of ciclesonide active metabolite in the rat lung after 4-week inhalation of ciclesonide Pulm. Pharmacol. Ther. 18 2006 390 396 (Pubitemid 41354264)
50. R. Buhl, I. Vinkler, P. Magyar, Z. Györi, C. Rybacki, M.V. Middle, A. Escher, and R. Engelstätter Comparable efficacy of ciclesonide once daily versus fluticasone propionate twice daily in asthma Pulm. Pharmacol. Ther. 19 2006 404 412 (Pubitemid 44234118)
51. M. Adachi, K. Ishihara, H. Inoue, K. Kudo, K. Takahashi, Y. Morita, K. Masuda, Y. Takada, R. Kato, and T. Miyamoto Efficacy and safety of inhaled ciclesonide compared with chlorofluorocarbon beclomethasone dipropionate in adults with moderate to severe persistent asthma Respirology 12 2007 573 580 (Pubitemid 46961837)
52. P. Christie Ciclesonide: a novel inhaled corticosteroid for asthma Drugs Today (Barc.) 40 2004 569 576 (Pubitemid 39281174)
53. C.L. Leach, T.D. Bethke, R.J. Boudreau, B.E. Hasseiquist, A. Drollmann, P. Davidson, and W. Wurst Two-dimensional and three dimensional imaging show ciclesonide has high lung deposition and peripheral distribution: a nonrandomized study in healthy volunteers J. Aerosol Med. 19 2006 117 126 (Pubitemid 43993378)
54. A. Weinbrenner, D. Hüneke, M. Zschiesche, G. Engel, W. Timmer, V.W. Steinijans, T. Bethke, W. Wurst, A. Drollmann, H.J. Kaatz, and W. Siegmund Circadian rhythm of serum cortisol after repeated inhalation of the new topical steroid ciclesonide J. Clin. Endocrinol. Metab. 87 2002 2160 2163 (Pubitemid 34521503)
55. D.S. Postma, C. Sevette, Y. Martinat, N. Schlosser, J. Aumann, and J. Kafe Treatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or evening Eur. Respir. J. 17 2001 1083 1088 (Pubitemid 32717462)
56. Dieter Ukena, Christian Biberger, Volker Steinijans, Volker von Behren, Ronitta Malek, Hans H. Weber, Ekkehard Beck, and Anneliese Linnhoff Ciclesonide is more effective than budesonide in the treatment of persistent asthma Pulm. Pharmacol. Ther. 20 2007 562 570 (Pubitemid 47077649)
57. G.E. D'Alonzo, M.H. Smolensky, S. Feldman, L.A. Gianotti, M.B. Emerson, H. Staudinger, and V.M. Steinijans Twenty-four-hour lung function in adult patients with asthma: chronoptimized theophylline therapy once daily dosing in the evening versus conventional twice-daily dosing Am. Rev. Respir. Dis. 142 1990 84 90 (Pubitemid 20224583)
58. P.D. Goldenheim, E.A. Conrad, and L.K. Schein Treatment of asthma by a controlled-release theophylline tablet formulation: a review of the North American experience with nocturnal dosing Chronobiol. Int. 4 1987 397 408 (Pubitemid 18065812)
59. V.W. Steinijans, H.U. Schulz, W. Beier, and H.W. Radtke Once daily theophylline: multiple-dose comparison of an encapsulated micro-osmotic system (Euphylong) with a tablet (Uniphyllin) Int. J. Clin. Pharmacol. 24 1986 43 47
60. D.L. Munday, and A.R. Fassihi In vitro-in vivo correlation studies on a novel controlled release theophylline delivery system and on Theo-Dur tablets Int. J. Pharm. 118 1995 251 255
61. T. Hayashi, H. Kanbe, M. Okada, M. Suzuki, Y. Ikeda, Y. Onuki, T. Kaneko, and T. Sonobe Formulation study and drug release mechanism of a new theophylline sustained-release preparation Int. J. Pharm. 304 2005 91 101 (Pubitemid 41427653)
62. M. Kraft, J.A. Torvik, J. Trudeau, S.E. Wenzel, R.J. Martin, and M.D Theophylline: potential anti-inflammatory effects in nocturnal asthma J. Allergy Clin. Immunol. 97 6 1996 1242 1246 (Pubitemid 26192273)
63. S. Leslie Euroceltique 1982 SA 20
64. S. Leslie The Contin delivery system: dosing considerations J. Allergy Clin. Immunol. 78 1986 768 773 (Pubitemid 17170594)
65. W.W. Arkinstall Review of the North American experience with evening administration of Uniphyl tablets, a once-daily theophylline preparation, in the treatment of nocturnal asthma Am. J. Med. 85 1988 60 63
66. R.M. Bogin, and R.D. Ballard Treatment of nocturnal asthma with pulse release albuterol Chest 102 1992 362 366
67. M.L. Powell, M. Weisberger, Y. Dowdy, R. Gural, S. Symchowicz, and J.E. Patrick Comparative steady-state bioavailability of conventional and controlled-release formulations of albuterol Biopharm. Drug Dispos. 8 1987 461 467
68. A.M. Bollinger, K.Y.L. Young, J.G. Gambertoglio, C.J.L. Newth, G. Zureikat, M. Powell, P. Leung, M.B. Affirme, S. Symchowicz, and J.E. Patrick Influence of food on the absorption of albuterol Repetabs J. Allergy Clin. Immunol. 83 1989 123 126 (Pubitemid 19052823)
69. J. Grossman, R.J. Morris, K.D. White, and M. Cocchetto Improved stability in oral delivery of albuterol provides less variability in bronchodilation in adults with asthma Ann. Allergy 66 1991 324 327
70. R.S. Sykes, M.E. Reese, M.C. Meyer, and J.M. Chubb Relative bioavailability of a controlled-release albuterol formulation for twice-daily use Biopharm. Drug Dispos. 9 1988 551 556
71. D.S. Postma, G.H. Koeter, J.J. Keyzer, and H. Meurs Influence of slow release terbutaline on the circadian variation of catecholamines, histamine, and lung function in nonallergic patients with partly reversible airflow obstruction J. Allergy Clin. Immunol. 77 1986 471 477 (Pubitemid 16135700)
72. D.S. Postma, G.H. Koeter, T.W.v.d. Mark, R.P. Reig, and H.J. Sluiter The effects of oral slow-release terbutaline on the circadian variation in spirometry and arterial blood gas levels in patients with chronic airflow obstruction Chest 87 1985 653 657 (Pubitemid 15092122)
73. G.H. Koeter, D.S. Postma, J.J. Keyzer, and H. Meurs Effect of oral slow release terbutaline on early morning dyspnea Eur. J. Clin. Pharmacol. 28 1985 159 162 (Pubitemid 15143777)
74. R. Dahl, H. Harving, L. Sawedal, and S. Anchus Terbutaline sustained release tablets in nocturnal asthma - a placebo-controlled comparison between a high and low evening dose Br. J. Dis. Chest 82 1988 237 241
75. J. Moore-Gillon Volmax (salbutamol CR 8 mg) in the management of nocturnal asthma: a placebo-controlled study Eur. Respir. J. 1 Suppl. 2 1988 306s (Abstract)
76. J.D. Creemers A multicenter comparative study of salbuterol controlled release (Volmax) and sustained-release theophylline (Theo-Dur) in the control of nocturnal asthma Eur. Respir. J. 1 Suppl. 2 1988 333s (Abstract)
77. B.K. Pedersen, L.C. Laursen, Y. Gnosspelius, P. Faurschou, and B. Weeks Bambuterol: effects of a new anti-asthmatic drug Eur. J. Clin. Pharmacol. 29 1985 425 427 (Pubitemid 16192598)
78. G. Persson, Y. Gnosspelius, and S. Anehus Comparison between a new once daily bronchodilating drug, bambuterol, and terbutaline sustained release, twice-daily Eur. Respir. J. 1 1988 223 226
79. G. Persson, O. Pahlm, and Y. Gnosspellus Oral bambuterol versus terbutaline in patients with asthma Curr. Ther. Res. 56 5 1995 457 465
80. P. Arvidsson, S. Larsson, C.G. Lofdahl, B. Melander, N. Svedmyr, and L. Wahlander Inhaled formoterol during one year in asthma: a comparison with salbutamol Eur. Respir. J. 4 1991 1168 1173
81. S. Kesten, K.R. Chapman, I. Broder, A. Cartier, and R.H. Hyland Sustained improvement in asthma with long-term use of formoterol fumarate Ann. Allergy 69 1992 415 420
82. D.I. Ball, R.T. Brittain, R.A. Coleman, L.H. Denyer, D. Jack, M. Johnson, L.H.C. Lunts, A.T. Nials, K.E. Sheldrick, and I.F. Skidmore Salmeterol, a novel, long-acting beta2-adrenergic agonist: characterization of pharmacological activity in vitro and in vivo Br. J. Pharmacol. 104 1991 665 671
83. E. Derom, R. Pauwels, and M. Van Der Straeten Duration of the protective effect of salmeterol on methacholine challenge of asthmatics Am. Rev. Respir. Dis. 141 1990 A469 (Suppl.) (Abstract)
84. J.L. Malo, H. Ghezzo, C. Trudeau, J.L. Archeveque, and A. Cartier Salmeterol, a new inhaled beta2-adrenergic agonist, has longer blocking effect than albuterol on hyperventilation-induced bronchoconstriction J. Allergy Clin. Immunol. 89 1992 567 574
85. O.P. Twentyman, J.P. Finnerty, A. Harris, J. Palmer, and S.T. Holgate Protection against allergen-induced asthma by salmeterol Lancet 336 1990 1338 1342
86. C. Brambilla, C. Chastang, D. Georges, and L. Bertin Salmeterol compared with slow-release terbutaline in nocturnal asthma Allergy 49 1994 421 426 (Pubitemid 24180108)
87. A. Ullman, J. Hedner, and N. Svedmyr Inhaled salmeterol and salbutamol in asthmatic patients Am. Rev. Respir. Dis. 142 1990 571 575
88. J. Qureshi, A. Mohd, and S. Arora Chronomodulated drug delivery system of salbutamol sulphate for the treatment of nocturnal asthma Ind. J. Pharm. Sci. 70 2008 351 356
89. P. Faurschou, A.M. Engel, and O.C. Haanaes Salmeterol in two different doses in the treatment of nocturnal bronchial asthma poorly controlled by other therapies Allergy 49 1994 827 832
90. T. Horiguchi, R. Kondo, J. Miyazaki, K. Fukumokto, and H. Torigoe Clinical evaluation of a transdermal therapeutic system of the beta2-agonist tulobuterol in patients with mild or moderate persistent bronchial asthma Arzneimittelforschung 54 2004 280 285 (Pubitemid 38698167)
91. N. Burioka, M. Miyata, M. Endo, Y. Fukuoka, H. Suyama, H. Nakazaki, K. Igawa, and E. Shimizu Alteration of the circadian rhythm in peak expiratory flow of nocturnal asthma following night time transdermal beta2-adrenoceptor agonist tulobuterol chronotherapy Chronobiol. Int. 22 2005 383 390 (Pubitemid 40967238)
92. M. Kraft Corticosteroids and leukotrienes: chronobiology and chronotherapy Chronobiol. Int. 16 1999 683 693 (Pubitemid 29463835)
93. J.P. Kemp Recent advances in the management of asthma using leukotriene modifiers Am. J. Respir. Med. 2 2003 139 156 (Pubitemid 37062723)
94. J.M. Drazen, E. Israel, and P.M. O'Byrne Treatment of asthma with drugs modifying the leukotriene pathway N. Engl. J. Med. 340 1999 197 206 (Pubitemid 29063217)
95. M. Pajaron-Fernandez, S. Garcia-Rubia, M. Sanchez-Solis, and L. Garcia-Marcos Montelukast administered in the morning or evening to prevent exercise-induced bronchoconstriction in children Pediatr. Pulmonol. 41 2006 222 227
96. T.F. Reiss, P. Chervinsky, R.J. Dockhorn, S. Shingo, B. Seidenberg, and T.B. Edwards Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial, Montelukast Clinical Research Study Arch. Intern. Med. 158 1998 1213 1220 (Pubitemid 28252484)
97. M.J. Noonan, P. Chervinsky, M. Brandon, J. Zhang, S. Kundu, J. McBurney, and T.F. Reiss Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group Eur. Respir. J. 11 1998 1232 1239 (Pubitemid 28298582)
98. L.C. Altman, Z. Munk, J. Seltzer, N. Noonan, S. Shingo, J. Zhang, and T.F. Reiss A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group J. Allergy Clin. Immunol. 102 1998 50 56 (Pubitemid 28345784)
99. Y. Qiu, H. Cheskin, J. Briskin, and K. Engh Sustained-release hydrophilic matrix tablets of zileuton: formulation and in vitro/in vivo studies J. Control. Release 45 1997 249 256 (Pubitemid 27062976)
100. S.E. Wenzel, J.B. Trudeau, and D.A. Kaminsky Effect of 5-lipoxygenase inhibition on bronchoconstriction and airways inflammation in nocturnal asthma Am. J. Respir. Crit. Care Med. 152 1995 897 905
101. Stelios T. Tzannis, William J.M. Hrushesky, Patricia A. Wood, and Todd M. Przybycien Irreversible inactivation of interleukin 2 in a pump-based delivery environment Proc. Natl. Acad. Sci. U. S. A. 93 May 1996 5460 5465 Applied Biological Sciences (Pubitemid 26159472)